Fish oil supplements, particularly those high in docosahexaenoic acid (DHA), were thought to enhance cognitive function. However, a recent study conducted at the USC School of Medicine found that while DHA reaches the brain, it does not improve memory or slow cognitive decline in older adults at risk for Alzheimer’s disease.
Study Overview and Findings
The clinical trial involved 365 participants aged between 55 and 80 who rarely consumed fish. Almost half of the participants (47%) had the APOE ε4 allele, a genetic risk factor for late-onset Alzheimer’s. Participants were divided into two groups, with one receiving a daily supplement of 2,000 mg of DHA and the other a placebo for 24 months.
Measurements of DHA levels indicated a 17% increase in the cerebrospinal fluid of the DHA group after six months. Despite this, cognitive tests revealed no significant differences in memory or cognitive performance between the DHA and placebo groups.
Why DHA Supplements Failed to Show Benefits
Researchers propose several reasons for the lack of cognitive improvement despite DHA reaching the brain. One theory involves the enzyme calcium-dependent phospholipase A2 (cPLA2), which may disrupt DHA metabolism, preventing its incorporation into synaptic membranes crucial for cognitive function.



